This is a ready-to-use validation protocol for a rapid or alternative microbiological method (RMM) intended for environmental monitoring, in-process bioburden, or a related microbiological application. It follows the three-component structure USP <1223> requires: instrument qualification, validation of the alternative technology, and method suitability for the specific sample matrix. Replace every <<FILL: ...>> placeholder and route it through your normal validation review and approval. A filled specimen follows. Verify each cited reference against the current source before you rely on it. This content is general educational reference, not legal or regulatory advice.
1. Approval page
| Role | Name | Signature | Date |
|---|---|---|---|
| Author (Microbiology / Validation) | <<FILL>> | ||
| Micro SME / EM program owner | <<FILL>> | ||
| Quality Assurance | <<FILL>> | ||
| System owner (instrument) | <<FILL>> |
| Field | Entry |
|---|---|
| Protocol number | <<FILL: VAL-RMM-###>> |
| Method / technology | <<FILL: e.g. ATP bioluminescence, flow cytometry, solid-phase cytometry>> |
| Instrument / platform, version | <<FILL>> |
| Intended application(s) | <<FILL: EM surface, EM air, in-process bioburden, WFI, other>> |
| Reference (compendial) method | <<FILL: e.g. USP <61>/<62> plate count, membrane filtration>> |
| Protocol version / date | <<FILL>> |
2. Objective
Provide documented evidence that the alternative method performs as intended for its stated application(s), in line with USP <1223> and, where the method output is qualitative rather than quantitative, that the distinction is clearly established and controlled.
3. Scope
In scope: the instrument and software as configured for <<FILL: site/lab>>, the comparability study against the reference method, and method suitability for each sample matrix listed in section 7C. Out of scope: any application or matrix not listed; a method suitability finding for one matrix does not extend to an untested matrix.
4. System description
<<FILL: measurement principle (ATP bioluminescence, flow cytometry, etc.), qualitative or quantitative output, vendor and model, software version, intended result type (presence/absence, relative light units, viable cell count)>>
5. Prerequisites
- Instrument qualification (IQ/OQ/PQ) complete and current; see analytical instrument qualification.
- Reference (compendial) method currently validated and in routine use as the comparator.
- A defined panel of challenge organisms representative of the facility’s recovered flora, including at least one Gram-positive, one Gram-negative, one spore-former, and one yeast or mold where the application warrants it.
- Sample matrices identified for method suitability testing (see section 7C).
6. Roles and acceptance
Each test case is executed by <<FILL: tester role, e.g. QC Microbiology>> and independently reviewed by <<FILL: Micro SME or QA>>. A case passes when the actual result equals the expected result with objective, dated evidence. A comparability or method-suitability finding that does not meet the pre-defined acceptance criterion is treated as a protocol deviation, not a footnote; the method is not released for the affected application or matrix until resolved.
7. Test cases
A. Instrument qualification
Referenced from the IQ/OQ/PQ package (attachment, not reproduced here). Confirm currency and applicability to this configuration before proceeding.
B. Validation of the alternative technology (comparability to the reference method)
| ID | Requirement | Test step | Expected result |
|---|---|---|---|
| RMM-01 | Accuracy | Test each challenge organism at a defined inoculum level by both the RMM and the reference method | RMM result within the pre-defined agreement criterion of the reference method result |
| RMM-02 | Precision (repeatability) | Test a mid-level challenge organism in replicate (recommend n = 10) on the RMM | Relative standard deviation within the pre-defined acceptance limit |
| RMM-03 | Ruggedness | Vary a normal operating parameter (analyst, day, reagent lot) and repeat a challenge test | Result remains within acceptance across all varied conditions |
| RMM-04 | Specificity | Test a non-target or interfering substance relevant to the matrix | No false-positive signal, or a documented and controlled interference profile |
| RMM-05 | Limit of detection | Test a dilution series down to a low challenge level | Method detects down to the claimed limit of detection, consistent with the intended application |
| RMM-06 | Equivalence / non-inferiority (if replacing the reference method) | Statistical comparison of RMM versus reference method results across the full challenge panel | Pre-defined statistical criterion for equivalence or non-inferiority met |
C. Method suitability (per sample matrix)
Repeat for each matrix listed; a pass on one matrix does not extend to another.
| Matrix | Challenge organism(s) | RMM result | Reference method result | Result |
|---|---|---|---|---|
<<FILL: e.g. stainless steel surface swab>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
<<FILL: e.g. Grade A air sample>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
<<FILL: e.g. product matrix for in-process bioburden>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
8. Deviation handling
| Dev # | Test case | Description | Disposition |
|---|---|---|---|
<<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
A failure in accuracy, equivalence, or a method-suitability matrix must be resolved (adjusted acceptance criteria with statistical justification, or exclusion of the affected matrix/application from the validated scope) before the summary is signed.
9. Acceptance criteria (protocol level)
- Instrument qualification current and referenced.
- Accuracy, precision, ruggedness, specificity, and limit of detection all meet pre-defined criteria across the challenge organism panel.
- Where the method replaces the compendial reference method, statistical equivalence or non-inferiority demonstrated across the panel.
- Method suitability demonstrated separately for every matrix in the intended scope; no matrix is validated by inference from another.
- The qualitative-versus-quantitative nature of the method’s output is stated plainly in the summary and carried into the operating SOP.
10. Summary and conclusion
<<FILL: statement that the method is validated for the stated application(s) and matrices, or the conditions/restrictions on use; signed by Micro SME and QA>>
11. Attachments
- Instrument qualification package (referenced).
- Raw comparability and method-suitability data.
- Statistical analysis supporting equivalence/non-inferiority, if applicable.
- Deviation records and resolutions.
Filled specimen: RMM-01 (accuracy, flow cytometry versus plate count)
| Field | Entry |
|---|---|
| Test case | RMM-01, accuracy against reference plate count |
| Challenge organism | Staphylococcus epidermidis, ATCC reference strain |
| Inoculum level | Target 50 to 100 CFU per sample, verified by the reference method |
| RMM result | Viable cell count 78 events |
| Reference method result | 74 CFU by membrane filtration and plate count |
| Acceptance criterion | RMM result within +/-30% of the reference method result for this challenge level |
| Result | Pass; 5.4% relative difference |
| Evidence | Instrument output report FC-RMM01; plate count bench sheet PC-RMM01 |
The reference method’s own count carries its own variability, which is why the acceptance criterion is stated as a defined agreement band rather than an exact match; a flow cytometry count and a plate count are two different measurement principles counting overlapping but not identical populations (for example, viable-but-nonculturable cells the plate count cannot recover).
Common inspection findings this protocol prevents
- An RMM adopted for routine use with instrument qualification complete but no comparability study ever run against the compendial reference method.
- Method suitability assumed from a vendor’s general validation data rather than demonstrated against the facility’s own sample matrices.
- A qualitative screening technology (ATP bioluminescence) used and reported as if it produced a quantitative, CFU-equivalent result.
- No statistical basis stated for an equivalence or non-inferiority claim when the RMM is used to replace, rather than supplement, the compendial method.
How to adapt this protocol
- Build the challenge organism panel from your facility’s own recovered flora, not a generic list, so the validation reflects what the method will actually encounter.
- Set the accuracy and equivalence acceptance criteria before testing begins, with a documented statistical rationale, not after seeing the data.
- Add a matrix row in section 7C for every distinct sample type and application the method will be used for; do not extrapolate a pass from one matrix to another.
- If the method is qualitative only, state that limitation explicitly in the summary and in the operating SOP, and define how species-level identification will still be obtained when needed.
- Confirm the current edition of USP <1223> and any relevant Ph. Eur. 5.1.6 alignment before finalizing acceptance criteria.